Carmo João, Teles Rui Campante, Madeira Sérgio, Ferreira António, Brito João, Nolasco Tiago, Gonçalves Pedro de Araújo, Gabriel Henrique Mesquita, Raposo Luís, Vale Nelson, Ribeiras Regina, Abecasis Miguel, Almeida Manuel de Sousa, Neves José Pedro, Mendes Miguel
Departamento de Cardiologia, Hospital de Santa Cruz, Centro Hospitalar Lisboa Ocidental, Lisboa, Portugal.
Departamento de Cardiologia, Hospital de Santa Cruz, Centro Hospitalar Lisboa Ocidental, Lisboa, Portugal.
Rev Port Cardiol (Engl Ed). 2018 Jul;37(7):585-590. doi: 10.1016/j.repc.2017.09.028. Epub 2018 Jun 29.
Surgical risk scores are widely used to identify patients at high surgical risk who may benefit from transcatheter aortic valve implantation (TAVI). A multiparametric TAVI mortality risk score based on a French registry (FRANCE-2) has recently been developed. The aim of our study was to compare the 30-day mortality prediction performance of the FRANCE-2, EuroSCORE II and STS scores.
We retrospectively studied 240 patients from a single-center prospective registry who underwent TAVI between January 2008 and December 2015. All scores were assessed for calibration and discrimination using calibration-in-the-large and ROC curve analysis, respectively.
The observed mortality was 5.8% (n=14). The median EuroSCORE II, STS and FRANCE-2 scores were 5.0 (IQR 3.2-8.3), 5.1 (IQR 3.6-7.1) and 2.0 (IQR 1.0-3.0), respectively. Discriminative power was greater for EuroSCORE II (C-statistic 0.67) and STS (C-statistic 0.67) than for FRANCE-2 (C-statistic 0.53), but this was not statistically significant (p=0.26). All scores showed adequate calibration.
All scores showed modest performance in early mortality prediction after TAVI. Despite being derived from a TAVI population, FRANCE-2 was no better than surgical risk scores in our population.
手术风险评分被广泛用于识别手术风险较高的患者,这些患者可能从经导管主动脉瓣植入术(TAVI)中获益。最近基于法国注册研究(FRANCE-2)开发了一种多参数TAVI死亡率风险评分。我们研究的目的是比较FRANCE-2、欧洲心脏手术风险评估系统II(EuroSCORE II)和胸外科医师协会(STS)评分对30天死亡率的预测性能。
我们回顾性研究了2008年1月至2015年12月期间在单中心前瞻性注册研究中接受TAVI的240例患者。分别使用大样本校准和ROC曲线分析评估所有评分的校准和区分能力。
观察到的死亡率为5.8%(n = 14)。EuroSCORE II、STS和FRANCE-2评分的中位数分别为5.0(四分位间距[IQR] 3.2 - 8.3)、5.1(IQR 3.6 - 7.1)和2.0(IQR 1.0 - 3.0)。EuroSCORE II(C统计量0.67)和STS(C统计量0.67)的区分能力大于FRANCE-2(C统计量0.53),但差异无统计学意义(p = 0.26)。所有评分均显示出充分的校准。
所有评分在TAVI术后早期死亡率预测方面表现一般。尽管FRANCE-2源自TAVI人群,但在我们的研究人群中,其并不优于手术风险评分。